Cellular contamination pathway for plutonium, other heavy elements, identified
Scientists find that an iron-binding protein can transport actinides into cells
Scientists at Lawrence Berkeley National Laboratory have reported an advance in understanding the biological chemistry of radioactive metals, opening up new avenues of research into strategies for remedial action in the event of possible human exposure to nuclear contaminants.
Crystals formed with the protein siderocalin and curium complexes exhibit bright red luminescence when exposed to UV light.
Lawrence Berkeley National Laboratory
Research led by Berkeley Lab's Rebecca Abergel, working with the Fred Hutchinson Cancer Research Center in Seattle, has found that plutonium, americium, and other actinides can be transported into cells by an antibacterial protein called siderocalin, which is normally involved in sequestering iron.
Their results contain several other findings and achievements, including characterization of the first ever protein structures containing transuranic elements and how use of the protein can sensitize the metal's luminescence, which could lead to potential medical and industrial applications.
Abergel's group has already developed a compound to sequester actinides and expel them from the body. They have put it in a pill form that can be taken orally, a necessity in the event of radiation exposure amongst a large population. Last year the FDA approved a clinical trial to test the safety of the drug.
However, a basic understanding of how actinides act in the body was still not well known. "Although [actinides] are known to rapidly circulate and deposit into major organs such as bone, liver, or kidney after contamination, the specific molecular mechanisms associated with mammalian uptake of these toxic heavy elements remain largely unexplored," Abergel and her co-authors wrote.
The current research identifies a new pathway for the intracellular delivery of the radioactive toxic metal ions, and thus a possible new target for treatment strategies. The scientists used cultured kidney cells to demonstrate the role of siderocalin in facilitating the uptake of the metal ions in cells.
"We showed that this protein is capable of transporting plutonium inside cells," she said. "So this could help us develop other strategies to counteract actinide exposure. Instead of binding and expelling radionuclides from the body, we could maybe block the uptake."
The team used crystallography to characterize siderocalin-transuranic actinide complexes, gaining unprecedented insights into the biological coordination of heavy radioelements. "These are the first protein structures containing thorium or the transuranic elements plutonium, americium, or curium," Abergel said. "Until this work there was no structure in the Protein Data Bank that had those elements. That's an exciting thing for us."
Original publication
Other news from the department science
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
